Efficacy of Ticagrelor vs Clopidogrel in High-risk NSTE-ACS Patients Undergoing Early PCI
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 444 participants.
Also called NCT02201667
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 444 participants
- Sponsor
- Registry
-
NCT02201667
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT02201667. Randomized; no masking; primary purpose treatment. Start 2014-08 (registry gives no type); primary completion 2016-08 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy of Ticagrelor vs Clopidogrel in High-risk NSTE-ACS Patients Undergoing Early PCI
- Condition
- Acute Coronary Syndrome
- Intervention (Drug)
- Ticagrelor
- Intervention (Drug)
- clopidogrel
- Intervention (Drug)
- Aspirin
- Intervention (Procedure)
- PCI (percutaneous coronary intervention)
- Lead sponsor
- RenJi Hospital
Record details
- Record id
cardio:ct-nct02201667- Content hash
bd1132e10d98edc41e4973f2aa863130978ddaaf15ae453029983bb8ff072904